company background image
600285 logo

Henan Lingrui Pharmaceutical XSSC:600285 Stock Report

Last Price

CN¥20.81

Market Cap

CN¥11.7b

7D

-3.5%

1Y

22.1%

Updated

23 Nov, 2024

Data

Company Financials +

Henan Lingrui Pharmaceutical Co., Ltd.

XSSC:600285 Stock Report

Market Cap: CN¥11.7b

Henan Lingrui Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Henan Lingrui Pharmaceutical
Historical stock prices
Current Share PriceCN¥20.81
52 Week HighCN¥27.26
52 Week LowCN¥16.07
Beta0.34
11 Month Change-16.99%
3 Month Change-14.43%
1 Year Change22.12%
33 Year Change63.86%
5 Year Change103.02%
Change since IPO150.72%

Recent News & Updates

Recent updates

Shareholder Returns

600285CN PharmaceuticalsCN Market
7D-3.5%-1.5%-2.1%
1Y22.1%-9.4%2.8%

Return vs Industry: 600285 exceeded the CN Pharmaceuticals industry which returned -9.4% over the past year.

Return vs Market: 600285 exceeded the CN Market which returned 2.8% over the past year.

Price Volatility

Is 600285's price volatile compared to industry and market?
600285 volatility
600285 Average Weekly Movement7.5%
Pharmaceuticals Industry Average Movement7.3%
Market Average Movement8.3%
10% most volatile stocks in CN Market12.6%
10% least volatile stocks in CN Market5.6%

Stable Share Price: 600285 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 600285's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19922,530Wei Xiongwww.lingrui.com

Henan Lingrui Pharmaceutical Co., Ltd. produces and sells medicines in China. The company offers its products in ten dosage forms, such as adhesive plasters, tablets, capsules, granules, tinctures, etc. covering various product varieties. Its products include Tongluoqutong plasters, Peiyuantongnao capsules, Danlutongdu tablets, stomachache free tablets, Shenqi Hypoglycemic capsules, and others.

Henan Lingrui Pharmaceutical Co., Ltd. Fundamentals Summary

How do Henan Lingrui Pharmaceutical's earnings and revenue compare to its market cap?
600285 fundamental statistics
Market capCN¥11.72b
Earnings (TTM)CN¥675.80m
Revenue (TTM)CN¥3.56b

17.3x

P/E Ratio

3.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600285 income statement (TTM)
RevenueCN¥3.56b
Cost of RevenueCN¥942.20m
Gross ProfitCN¥2.62b
Other ExpensesCN¥1.95b
EarningsCN¥675.80m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Nov 25, 2024

Earnings per share (EPS)1.20
Gross Margin73.56%
Net Profit Margin18.96%
Debt/Equity Ratio0.4%

How did 600285 perform over the long term?

See historical performance and comparison

Dividends

3.8%

Current Dividend Yield

66%

Payout Ratio